Sky View Investment Advisors, LLC Biocryst Pharmaceuticals Inc Transaction History
Sky View Investment Advisors, LLC
- $698 Million
- Q2 2025
A detailed history of Sky View Investment Advisors, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Sky View Investment Advisors, LLC holds 10,766 shares of BCRX stock, worth $74,608. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,766
Previous 10,500
2.53%
Holding current value
$74,608
Previous $79,000
22.78%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding BCRX
# of Institutions
313Shares Held
201MCall Options Held
930KPut Options Held
553K-
Vanguard Group Inc Valley Forge, PA20.5MShares$142 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$138 Million0.0% of portfolio
-
State Street Corp Boston, MA8.51MShares$58.9 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.46MShares$58.7 Million9.06% of portfolio
-
Alkeon Capital Management LLC New York, NY5.71MShares$39.6 Million0.09% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.29B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...